INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 102 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2017. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $97,000 | +19.8% | 3,775 | -65.0% | 0.03% | +28.6% |
| Q3 2019 | $81,000 | -60.1% | 10,800 | +20.0% | 0.02% | -44.7% |
| Q3 2018 | $203,000 | +21.6% | 9,000 | -4.3% | 0.04% | 0.0% |
| Q2 2018 | $167,000 | +943.8% | 9,400 | +754.5% | 0.04% | +850.0% |
| Q4 2017 | $16,000 | -91.7% | 1,100 | -90.7% | 0.00% | -81.8% |
| Q1 2017 | $192,000 | +47.7% | 11,830 | +37.6% | 0.02% | +37.5% |
| Q4 2016 | $130,000 | – | 8,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |